| Category | Equity Leverage |
| Style | Equity Leverage |
| Net Expense Ratio * | |
| Turnover % | .00 |
The Fund seeks daily investment results of 300% of the performance of the S&P Biotechnology Select Industry Index. The Fund creates long positions by investing at least 80% of its assets in the securities that comprise the Index and/or financial instruments that provide leveraged and unleveraged exposure to the Index.
| Fund | -44.39 | -19.87 | - | - | - |
|---|---|---|---|---|---|
| Category | 20.84 | 32.36 | 5.60 | 17.52 | 3.99 |
| S&P 500 | 6.98 | 16.71 | 10.63 | 15.60 | 7.15 |
| % Rank in Category | 99 | 97 | - | - | - |
| Quintile Rank | 5 | 5 | - | - | - |
| Last 5 Days | OPEN | HIGH | LOW | CLOSE | VOLUME |
|---|---|---|---|---|---|
| 09/29/16 | 52.05 | 52.46 | 46.7501 | 46.96 | 2.62 M |
| 09/28/16 | 55.20 | 55.48 | 50.83 | 52.26 | 1.89 M |
| 09/27/16 | 52.51 | 55.11 | 52.01 | 54.64 | 1.82 M |
| 09/26/16 | 52.55 | 53.4499 | 51.80 | 52.61 | 1.35 M |
| 09/23/16 | 54.13 | 55.8799 | 53.2806 | 53.45 | 1.49 M |
N/A
| Name | % of Total Portfolio |
|---|---|
Fidelity Institutional Money Market Funds/Government Portfolio Cl I | 10.55% |
Financial Square Treasury Instruments Fund FST Shares | 4.76% |
SPDR S&P Biotech ETF | 0.42% |
Dreyfus Treasury Securities Cash Management Institutional Shares | 0% |
| Name | % of Total |
|---|---|
Health Care | 0.42% |
| DATE | INCOME DISTRIBUTION |
|---|---|
| 2015 | - |